Latest news articles

Added 15 days ago Drug news

Celgene submits MAA to EMA for ozanimod to treat relapsing-remitting multiple sclerosis

Celgene Corporation announced that the Company has submitted a Marketing Authorization Application to the European Medicines Agency (EMA) for ozanimod...

Added 3 months ago Drug news

Vumerity filed at FDA to treat relapsing-remitting MS. Biogen

Alkermes plc and Biogen Inc. announced that Alkermes has submitted a New Drug Application (NDA) to the FDA for diroximel...

Added 3 months ago Drug news

European Commission approves Gilenya to treat children and adolescents with r/r multiple sclerosis. - Novartis

Novartis announced that the European Commission (EC) has approved Gilenya (fingolimod) for the treatment of children and adolescents 10 to...

Search all news articles for Multiple sclerosis
 

Learning Zones

An epgonline.org Learning Zone (LZ) is an area of the site dedicated to providing detailed self-directed medical education about a disease, condition or procedure.

Migraine Knowledge Centre

Migraine Knowledge Centre

The Migraine Knowledge Centre features latest research on the prevalence and impact of migraine, the proposed neurological basis of the condition (and how this is being translated into new and exciting drug therapies), as well as current patient care strategies collated from headache organisations worldwide.

Cushing's Syndrome

Cushing's Syndrome

Cushing’s syndrome shares symptoms such as hypertension, glucose intolerance and obesity with other common conditions – how can you confidently diagnose this rare disorder?

+ 2 more

Load more

Guidelines

Association of British Neurologists: revised (2015) guidelines for prescribing disease-modifying treatments in multiple sclerosis

This 2015 revised guideline replaces former versions. It includes all newly approved or licensed treatments for MS and represents a consensus concerning their use.

Added 3 years ago

Multiple sclerosis in adults: management

This guideline covers diagnosing and managing multiple sclerosis in people aged 18 and over.

Added 4 years ago

Urinary incontinence in neurological disease: assessment and management

This guideline covers assessing and managing urinary incontinence in children, young people and adults with neurological disease.

Added 6 years ago

Search all guidelines for Multiple sclerosis
 

Journal articles

Alemtuzumab depletion failure can occur in multiple sclerosis.

Alemtuzumab is a lymphocyte-depleting antibody and one of the most effective treatments for relapsing multiple sclerosis. However, it also causes loss of immune-tolerance leading to secondary autoimmunity...

Added 8 months ago

Alemtuzumab for the treatment of multiple sclerosis.

In this review, the authors summarize biological, clinical and safety data related to the use of alemtuzumab in patients with MS.

Added 8 months ago

Risk of opportunistic infections in patients treated with alemtuzumab for multiple sclerosis.

In this review, we attempt to summarize all the available literature concerning opportunistic infections occurring in patients with MS receiving alemtuzumab.

Added 8 months ago

Search all journal articles for Multiple sclerosis
 

Clinical trials

A Study of Ocrelizumab in Comparison With Interferon Beta-1a (Rebif) in Participants With Relapsing Multiple Sclerosis

This randomized, double-blind, double-dummy, parallel-group study will evaluate the efficacy and safety of ocrelizumab in comparison with interferon beta-1a (Rebif) in participants with relapsing multiple sclerosis.

Added 1 year ago

A Study of Ocrelizumab in Participants With Primary Progressive Multiple Sclerosis

This randomized, parallel group, double-blind, placebo controlled study will evaluate the efficacy and safety of ocrelizumab in participants with primary progressive multiple sclerosis.

Added 1 year ago

An Efficacy Study of Teriflunomide in Participants With Relapsing Multiple Sclerosis (TOWER)

The primary objective of the study was to assess the effect of two doses of teriflunomide, in comparison to placebo, on the frequency of multiple sclerosis (MS) relapses in participants with relapsing MS.

Added 9 months ago

Search all clinical trials for Multiple sclerosis
 

CME

Multiple sclerosis: clinical review

Accrediting body
MIMS Learning - Monthly Index of Medical Specialities
Credits available
2
Registration required
0
Subscription fee
0
Search all CME for Multiple sclerosis